2022
DOI: 10.5005/ijcdas-53-2-107
|View full text |Cite
|
Sign up to set email alerts
|

Metastatic Pleural Effusion: A Rare Presentation of Salivary Gland Adenoid Cystic Carcinoma

Abstract: Adenoid cystic carcinoma, an uncommon malignant salivary gland neoplasm, is known for its long clinical course, indolent growth, local recurrence and late distant metastasis. We report an unusual case of adenoid cystic carcinoma of the palate in a 64-year-old woman, undiagnosed for more than 15 years, who presented as malignant pleural effusion.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(10 citation statements)
references
References 13 publications
0
10
0
Order By: Relevance
“…ACC is characterised by a protracted clinical course with multiple local recurrences and late metastatic spread. 2,3 Disease-free intervals have been reported to range between 1 month and 19 years, with a median interval of 36 months. 4 Distant haematogenous metastasis is more frequent than regional lymph node metastasis, and most commonly involves the lung, followed by liver and bone.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…ACC is characterised by a protracted clinical course with multiple local recurrences and late metastatic spread. 2,3 Disease-free intervals have been reported to range between 1 month and 19 years, with a median interval of 36 months. 4 Distant haematogenous metastasis is more frequent than regional lymph node metastasis, and most commonly involves the lung, followed by liver and bone.…”
Section: Discussionmentioning
confidence: 99%
“…4 Distant haematogenous metastasis is more frequent than regional lymph node metastasis, and most commonly involves the lung, followed by liver and bone. 1,2 Although ACC has a good short-term prognosis, its long-term prognosis is poor, with estimated survival rates of 68%, 52% and 28% at 5, 10 and 20 years, respectively. 5 Significant predictors of survival include tumour stage, nodal status, histological grade and patient age.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations